- Home
- QURE vs NBBK Comparison
QURE vs NBBK Comparison
Compare QURE & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | NBBK |
|---|---|---|
| Founded | 1998 | 1892 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 887.5M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | QURE | NBBK |
|---|---|---|
| Price | $27.85 | $20.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $45.00 | $23.50 |
| AVG Volume (30 Days) | ★ 1.9M | 218.7K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ 29.67 | 25.23 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $45.15 |
| Revenue Next Year | $200.43 | $4.18 |
| P/E Ratio | ★ N/A | $55.64 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $15.44 |
| 52 Week High | $71.50 | $22.86 |
Technical Indicators
Market Signals| Indicator | QURE | NBBK |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 47.84 |
| Support Level | $20.20 | $19.32 |
| Resistance Level | $29.03 | $20.67 |
| Average True Range (ATR) | 1.74 | 0.35 |
| MACD | -0.17 | 0.09 |
| Stochastic Oscillator | 75.56 | 71.21 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. The group's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, consumer loans, and other related services.